City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

Now, with tensions easing and the US$43.6 billion ($56.62 billion) raised in 2025 IPOs so far running just behind the same ...

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

This week, CATL, a leading domestic lithium battery company, launched its Hong Kong IPO, heating up the lithium battery sector.

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Market though is overflowing with rivals and fierce price clashes. Read more at straitstimes.com. Read more at ...

Chinese EV battery giant CATL aims to raise US$4 billion in its Hong Kong listing scheduled for May 20, said a statement ...